risperidone has been researched along with Amphetamine Abuse in 6 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Risperidone was well tolerated and associated with decreased MA use." | 2.73 | An open-label pilot study of risperidone in the treatment of methamphetamine dependence. ( Cherrier, M; Jaffe, C; Meredith, CW; Saxon, AJ; Yanasak, E, 2007) |
| " We compared the effects of withdrawal from long-term administration of the typical neuroleptic haloperidol (Hal) and/or the atypical agent risperidone (Ris) on MDS and NDS, behaviorally evaluated by amphetamine-induced locomotor stimulation (AILS) and apomorphine-induced stereotypy (AIS) in mice, respectively." | 1.35 | Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors. ( Callegaro-Filho, D; Carvalho, RC; Frussa-Filho, R; Fukushiro, DF; Helfer, DC; Sanday, L; Silva, RH; Trombin, TF; Zanlorenci, LH, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khoramizadeh, M | 1 |
| Effatpanah, M | 1 |
| Mostaghimi, A | 1 |
| Rezaei, M | 1 |
| Mahjoub, A | 1 |
| Shishehgar, S | 1 |
| Kishi, T | 1 |
| Matsuda, Y | 1 |
| Iwata, N | 1 |
| Correll, CU | 1 |
| Nejtek, VA | 1 |
| Avila, M | 1 |
| Chen, LA | 1 |
| Zielinski, T | 1 |
| Djokovic, M | 1 |
| Podawiltz, A | 1 |
| Kaiser, K | 1 |
| Bae, S | 1 |
| Rush, AJ | 1 |
| Carvalho, RC | 1 |
| Fukushiro, DF | 1 |
| Helfer, DC | 1 |
| Callegaro-Filho, D | 1 |
| Trombin, TF | 1 |
| Zanlorenci, LH | 1 |
| Sanday, L | 1 |
| Silva, RH | 1 |
| Frussa-Filho, R | 1 |
| Meredith, CW | 1 |
| Jaffe, C | 1 |
| Yanasak, E | 1 |
| Cherrier, M | 1 |
| Saxon, AJ | 1 |
| Marchesi, C | 1 |
| Tonna, M | 1 |
| Maggini, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder Outpatients With Current Stimulant Dependence[NCT00227123] | 96 participants (Actual) | Interventional | 2002-10-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for risperidone and Amphetamine Abuse
| Article | Year |
|---|---|
Treatment of amphetamine abuse/use disorder: a systematic review of a recent health concern.
Topics: Amphetamine-Related Disorders; Aripiprazole; Clinical Trials as Topic; Cognitive Behavioral Therapy; | 2019 |
Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
Topics: Amphetamine-Related Disorders; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Central Nervous | 2013 |
2 trials available for risperidone and Amphetamine Abuse
| Article | Year |
|---|---|
Do atypical antipsychotics effectively treat co-occurring bipolar disorder and stimulant dependence? A randomized, double-blind trial.
Topics: Adult; Amphetamine-Related Disorders; Antipsychotic Agents; Bipolar Disorder; Cocaine-Related Disord | 2008 |
An open-label pilot study of risperidone in the treatment of methamphetamine dependence.
Topics: Adult; Amphetamine-Related Disorders; Antipsychotic Agents; Central Nervous System Stimulants; Femal | 2007 |
2 other studies available for risperidone and Amphetamine Abuse
| Article | Year |
|---|---|
Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
Topics: Amphetamine-Related Disorders; Animals; Antipsychotic Agents; Apomorphine; Corpus Striatum; Dopamine | 2009 |
Obsessive-compulsive disorder followed by psychotic episode in long-term ecstasy misuse.
Topics: Adolescent; Amphetamine-Related Disorders; Antidepressive Agents, Tricyclic; Antipsychotic Agents; B | 2009 |